Patents by Inventor Mark James Schulz

Mark James Schulz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiazolopyrimidinone derivatives as PI3 kinase inhibitors
    Patent number: 8410095
    Abstract: This invention relates to novel compounds of formula (I): and derivatives thereof useful for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K?, PI3K?, and/or PI3K?.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: April 2, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Hong Lin, Juan I. Luengo, Ralph A. Rivero, Mark James Schulz, Ren Xie, Jin Zeng
  • THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS
    Publication number: 20120053147
    Abstract: This invention relates to novel compounds of formula (I): and derivatives thereof useful for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3? OH kinase family (hereinafter PI3 kinases), suitably, PI3K?, PI3K}, PI3K?, and/or PI3K?.
    Type: Application
    Filed: May 20, 2010
    Publication date: March 1, 2012
    Inventors: Hong Lin, Juan I Luengo, Ralph A. Rivero, Mark James Schulz, Ren Xie, Jin Zeng